Prolonged survival of an HIV-infected subject with severe lymphoproliferative disease and rhinocerebral mucormycosis.

NCCLS, Villanova, PA, USA, 2001. 3. Weill FX, Bertrand S, Guesnier F et al. Ciprofloxacinresistant Salmonella Kentucky in travelers. Emerg Infect Dis 2006; 12: 1611–2. 4. Baucheron S, Imberechts H, Chaslus-Dancla E et al. The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar Typhimurium phage type DT204. Microb Drug Resist 2002; 8: 281–9. 5. Bertrand S, Weill F-X, Cloeckaert A et al. Clonal emergence of extended-spectrum b-lactamase (CTX-M-2)-producing Salmonella enterica serovar Virchow isolates with reduced susceptibilities to ciprofloxacin among poultry and humans in Belgium and France (2000 to 2003). J Clin Microbiol 2006; 44: 2897–903. 6. Majtan V, Majtan T, Matjan J et al. Salmonella enterica serovar Kentucky: antimicrobial resistance and molecular analysis of clinical isolates from the Slovac Republic. Jpn J Infect Dis 2006; 59: 358–62.